• Medscape InDiscussion: Psoriasis

  • 著者: Medscape
  • ポッドキャスト

Medscape InDiscussion: Psoriasis

著者: Medscape
  • サマリー

  • Listen to Medscape InDiscussion: Psoriasis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986130). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
    Copyright 2023, Medscape
    続きを読む 一部表示

あらすじ・解説

Listen to Medscape InDiscussion: Psoriasis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986130). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Copyright 2023, Medscape
エピソード
  • S1 Episode 1: Sage Advice on Psoriasis and Quality-of-Life Assessment
    2022/04/05

    What drives patients with psoriasis to seek care? Dr Steven Feldman and Professor Andrew Finlay, inventor of the Dermatology Life Quality Index, explore what matters most to patients.

    Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/965160). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals.

    Resources

    How is the severity of psoriatic arthritis and psoriasis usually assessed? https://www.medscape.com/answers/2196539-155443/how-is-the-severity-of-psoriatic-arthritis-and-psoriasis-is-usually-assessed

    Dermatology Life Quality Index (DLQI) https://www.bad.org.uk/shared/get-file.ashx?id=1653&itemtype=document

    Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1365-2230.1994.tb01167.x

    Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data https://www.karger.com/Article/FullText/365390

    A Changed Life: The Life Experiences of Patients With Psoriasis Receiving Biological Treatment https://onlinelibrary.wiley.com/doi/10.1111/bjd.18876

    Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies https://pubmed.ncbi.nlm.nih.gov/23425140/

    続きを読む 一部表示
    23 分
  • S1 Episode 2: How to Quickly Spot and Manage Psoriasis Comorbidities
    2022/04/05

    What's the best way to screen for common comorbidities in patients with psoriasis, and how do the experts respond when clues of systemic disease show up?

    Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/965161). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals.

    Resources

    Psoriasis https://emedicine.medscape.com/article/1943419-overview#a6

    Axial Psoriatic Arthritis: An Update for Dermatologists https://www.jaad.org/article/S0190-9622(20)30959-2/fulltext

    Psoriatic Arthritis https://emedicine.medscape.com/article/2196539-overview

    Psoriatic Arthritis: State of the Art Review https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297592/pdf/clinmed-17-1-65.pdf

    Joint American Academy of Dermatology–National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologic Therapies https://www.jaad.org/article/S0190-9622(20)30284-X/fulltext

    Axial Spondyloarthritis https://ard.bmj.com/content/80/12/1511.long

    Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727454/pdf/40257_2020_Article_578.pdf

    Risankizumab, an IL-23 inhibitor, for Ankylosing Spondylitis: Results of a Randomized, Double-blind, Placebo-Controlled, Proof-of-concept, Dose-Finding Phase 2 Study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104676/pdf/annrheumdis-2018-213328.pdf

    Axial Involvement in Psoriatic Arthritis Cohort (AXIS): The Protocol of a Joint Project of the Assessment of SpondyloArthritis International Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721378/pdf/10.1177_1759720X211057975.pdf

    Three Multicenter, Randomized, Double-blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis https://onlinelibrary.wiley.com/doi/10.1002/art.40728

    Efficacy of Guselkumab on Axial Involvement in Patients With Active Psoriatic Arthritis and Sacroiliitis: A Post-Hoc Analysis of the Phase 3 DISCOVER-1 and DISCOVER-2 Studies https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(21)00105-3/fulltext

    Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients With Peripheral Arthritis and Physician-Reported Spondylitis: Post-hoc Analyses From Two Phase III, Multicentre, Double-blind, Placebo-Controlled Studies (PSUMMIT-1/PSUMMIT-2) https://ard.bmj.com/content/75/11/1984.long

    BASDAI Calculator https://qxmd.com/calculate/calculator_299/basdai

    Effectiveness, Costs and Cost-effectiveness of Chiropractic Care and Physiotherapy Compared With Information and Advice in the Treatment of Non-specific Chronic Low Back Pain: Study Protocol for a Randomised Controlled Trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741874/pdf/13063_2017_Article_2351.pdf

    Axial Involvement in Psoriatic Arthritis: An Update for Rheumatologists https://www.sciencedirect.com/science/article/pii/S0049017221001190?via%3Dihub

    Dactylitis: A Hallmark of Psoriatic Arthritis https://www.sciencedirect.com/science/article/pii/S0049017217306261?via%3Dihub

    Psoriasis Workup https://emedicine.medscape.com/article/1943419-workup#c2

    Treatment Guidelines in Psoriatic Arthritis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065461/pdf/kez383.pdf

    Risk of Myocardial Infarction in Patients With Psoriasis https://jamanetwork.com/journals/jama/fullarticle/203598

    Cardiovascular Disease Prevention for Psoriasis and Psoriatic Arthritis (CP3) https://www.med.upenn.edu/gelfand/research.html

    Primary Care-Based Screening for Cardiovascular Risk Factors in Patients With Psoriasis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113692/pdf/BJD-175-348.pdf

    Psoriasis: Comorbidities https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252780/pdf/JDE-48-732.pdf

    Changing Health Behaviours in Rheumatology: An Introduction to Behavioural Economics https://www.nature.com/articles/s41584-019-0336-1

    The Influence of Body Weight of Patients With Chronic Plaque Psoriasis on Biological Treatment Response https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262805/

    続きを読む 一部表示
    18 分
  • S1 Episode 3: Topical Prescribing Tips for Better Psoriasis Outcomes
    2022/05/05

    Dermatologists Steven Feldman and Melinda Gooderham share expert advice and go-to options for topical use in patients with psoriasis.

    Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/965162). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Joint AAD–NPF Guidelines of Care for the Management and Treatment of Psoriasis With Topical Therapy and Alternative Medicine Modalities for Psoriasis Severity Measures https://www.jaad.org/article/S0190-9622(20)32288-X/fulltext#secsectitle0050

    Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539972/

    Optimizing the Use of Topical Agents in Psoriasis https://www.scmsjournal.com/wp-content/uploads/2017/02/v33i2s-Optimizing-the-use-of-Topical-Agents.pdf

    続きを読む 一部表示
    23 分

Medscape InDiscussion: Psoriasisに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。